Institutional ticker directory tracking stock mentions, long/short ideas, and high-conviction pitches extracted from quarterly hedge fund letters.
| Ticker | Company | Sector | Industry | Pitches | Stance |
|---|---|---|---|---|---|
| Fund / Manager | Thesis Excerpt | Stance | Period / Date | Action |
|---|---|---|---|---|
RLH Capital Louis Camhi | “D. Boral ARC Acquisition I Corp. (Nasdaq: BCAR) announced its transaction with Exascale Labs in early January and at the time, the Fund had no position. The initial reaction was positive with shares trading up ~5%, however, the enthusiasm faded and shares began to trade lower in the coming months. The Fund began acquiring shares in March at ~$10.11 – at the time our estimate of cash in trust was ~$10.25. Our thesis was simple: Downside case: if the transaction didn't close and the SPAC liquidated in April 2027, we would generate a positive return. Base case: the transaction closes over the summer generating a high-single-digit to low-double-digit unlevered return. Upside case: strong investor demand given Exascale's position in the AI ecosystem results in shares trading above trust value. Our upside case played out, and shares traded up to $11.00 (estimated cash in trust was $10.35). As in most situations, especially larger positions, when a SPAC trades above trust we begin reducing our position. Once shares trade above trust, the trust floor no longer provides the same downside protection, and the prospective yield is no longer sufficiently compelling. We monetized approximately two-thirds of the position above trust and subsequent to quarter end expect to redeem the remaining one-third in connection with the transaction vote, currently anticipated for late July or early August.” | NEUTRAL | Q2 2026 Jul 29, 2026 | View Pitch |
Each excerpt above is the manager's commentary on this ticker specifically. The full letter has the rest of their portfolio thinking, risk discussion, and broader institutional context.
